The global immune BCG market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). BCG (stands for Bacille Calmette-Guérin) is the most widely used tuberculosis vaccine only currently available for being commercialized for the prevention of tuberculosis. This vaccine is generally administered to children at birth in countries with high incidence of tuberculosis. However, in low incidence regions, only children at high risk are typically immunized, whereas, adults are generally not immunized. However, adults (up to the age of 35) who are frequently exposed to drug-resistant tuberculosis may also be given BCG vaccine. The market growth is driven by a surge in the prevalence of tuberculosis coupled with the growth in the technological advancements for vaccine research. Moreover, rising government initiatives and emphasis on immunization programs all over the globe, also boost the market growth.
To Request a Sample of our Report on Immune BCG Market: https://www.omrglobal.com/request-sample/immune-bcg-market
Various advancements in the areas of mycobacterial immunology and genomics have fueled the research on multiple new experimental vaccines. This is further likely to offer futuristic opportunities for the market growth. In addition to this, the relatively low cost of these vaccines, along with the added high safety, low side effects, as well as the easy availability of the vaccine are the major drivers of the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market growth. Although, the vague responses of the BCG vaccine on immunity and a global shortage of the vaccine might act as a hindrance to the market growth.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Merck & Co., Inc., and InterVax Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Incubator Devices Market is Available @ https://www.omrglobal.com/industry-reports/immune-bcg-market
Global Immune BCG Market Report by Segment
By Type
- 0.5ml Package
- 1ml Package
- 2ml Package
- Others
By Application
- Hospitals
- Clinics
Global Immune BCG Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
